|
Demographic characteristics of patients and control subjects |
|||
| Characteristic |
CABG (n = 13) |
CAD (n = 9) |
Healthy (n = 9) |
|
|
|||
| Sex (males/females) |
8/5 |
5/4 |
4/5 |
| Age (years) |
64 ± 2 |
64 ± 2 |
63 ± 2 |
| Body mass index (kg/m2) |
27.6 ± 0.6 |
27.4 ± 0.7 |
26.5 ± 0.9 |
| Drug used |
|||
| ACE inhibitors/AngioII-blockers |
5 |
6 |
- |
| Digital |
3 |
0 |
- |
| Anti-arrhythmic |
1 |
0 |
- |
| β-blockers |
6 |
1 |
- |
| Calcium-channel antagonists |
4 |
1 |
- |
| AAS |
7 |
3 |
- |
|
Values are means ± SEM. AAS, acetylsalicylic acid; ACE, angiotensin-converting enzyme; CABG, patients who underwent coronary artery bypass grafting; CAD, patients with coronary artery disease who did not undergo surgery; healthy, control subjects without CAD. The three groups were similar with regard to all variables (P > 0.05). | |||
Soares et al. Critical Care 2005 9:R124 doi:10.1186/cc3042 |
|||